These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 204118

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [The densitometric evaluation of lipoprotein electrophoresis on acetate foil and agar-agarose gel].
    Herrmann VW, Reuter W, Starke I.
    Z Gesamte Inn Med; 1976 Dec 01; 31(23):988-91. PubMed ID: 190808
    [Abstract] [Full Text] [Related]

  • 3. [The effect of etofibrate on serum cholesterol and triglycerides (author's transl)].
    Dimroth H.
    Med Klin; 1979 Jun 01; 74(22):875-6. PubMed ID: 470785
    [Abstract] [Full Text] [Related]

  • 4. [Combination or monotherapy of hyperlipoproteinemia typus IIb, IV, V with clofibrate and m-inositolnicotinate or clofibrinic acid (author's transl)].
    Schwartzkopff W, Zschiedrich M.
    Med Klin; 1978 Feb 17; 73(7):231-9. PubMed ID: 203832
    [Abstract] [Full Text] [Related]

  • 5. Treatment of hyperlipoproteinemia type II with etofibrate.
    Gustafson A.
    Int J Clin Pharmacol Biopharm; 1979 Dec 17; 17(12):498-502. PubMed ID: 528096
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Diet and drug treatment of hyperlipidemia and atherosclerosis.
    Kuo PT.
    Ann Clin Lab Sci (1971); 1972 Dec 17; 2(4):322-4. PubMed ID: 4342101
    [No Abstract] [Full Text] [Related]

  • 9. [Comparison between combination therapy with clofibrate and beta-pyridylcarbinol and clofibrate monotherapy (author's transl].
    Mordasini R, Müller A, Klose G, Middelhoff G, Augustin J, Haase W, Greten H.
    MMW Munch Med Wochenschr; 1978 Apr 14; 120(15):525-8. PubMed ID: 206826
    [Abstract] [Full Text] [Related]

  • 10. [Changes in serum lipoproteins in patients with ischemic heart disease at an early age].
    Malamov E, Kiriakov A, Tsenov I, Kavrukova Iu, Kusitasev G.
    Vutr Boles; 1982 Apr 14; 21(2):91-8. PubMed ID: 7101895
    [Abstract] [Full Text] [Related]

  • 11. [Treatment of hyperlipoproteinaemia types IIa, IIb, IV and V with a combination of clofibrate and inositol nicotinate (author's transl)].
    Wilke H, Frahm H.
    Dtsch Med Wochenschr; 1976 Mar 12; 101(11):401-5. PubMed ID: 1253701
    [Abstract] [Full Text] [Related]

  • 12. Xanthomatosis and hyperlipoproteinemia; a review.
    Polano MK.
    Dermatologica; 1974 Mar 12; 149(1):1-9. PubMed ID: 4372111
    [No Abstract] [Full Text] [Related]

  • 13. [The when and how of therapy for hyperlipoproteinemia].
    Mordasini R.
    Schweiz Med Wochenschr; 1978 Jan 28; 108(4):113-9. PubMed ID: 203028
    [Abstract] [Full Text] [Related]

  • 14. Pirifibrate in the treatment of hyperlipoproteinemia: types IIa, IIb, and IV.
    Lopez Rodriguez J, Martorell J.
    Clin Ther; 1980 Jan 28; 3(4):234-41. PubMed ID: 7273061
    [Abstract] [Full Text] [Related]

  • 15. A physician's guide to hyperlipidemia.
    Fredrickson DS.
    Mod Concepts Cardiovasc Dis; 1972 Jul 28; 41(7):31-6. PubMed ID: 4343098
    [No Abstract] [Full Text] [Related]

  • 16. [Clofibrate therapy--the status quo].
    Reuter W.
    Z Gesamte Inn Med; 1982 Jan 15; 37(2):59-63. PubMed ID: 7080553
    [Abstract] [Full Text] [Related]

  • 17. Changes in lipids and lipoproteins in patients with hyperlipidemia type IIb, IV and V treated with different lipid lowering drugs.
    Hutt V, Wechsler JG, Klör HU, Ditschuneit H.
    Artery; 1980 Jan 15; 8(2):113-9. PubMed ID: 7458676
    [Abstract] [Full Text] [Related]

  • 18. Effect of hypolipidemic drugs on serum lipoproteins.
    Carlson LA, Olsson AG.
    Prog Biochem Pharmacol; 1979 Jan 15; 15():238-57. PubMed ID: 224397
    [No Abstract] [Full Text] [Related]

  • 19. Effect of calcium p-chlorphenoxyisobutyrate and calcium carbonate on plasma lipids and lipoproteins of patients with hyperlipoproteinaemia.
    Koskinen P, Inkovaara J, Ala-Kaila K, Salo M, Nikkari T.
    Ann Clin Res; 1977 Dec 15; 9(6):335-41. PubMed ID: 356720
    [Abstract] [Full Text] [Related]

  • 20. [Effect of a new synthetic compound (3-nicotinoyl-oxypropyl p-chlorophenoxy isobutyrate: I.612) on plasma lipids in patients with type IIa, IIb and IV hyperdyslipidemia].
    Bucalossi A, Buzzelli G, D'Alessandro A.
    Clin Ter; 1979 Apr 30; 89(2):127-49. PubMed ID: 226307
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.